Life sciences hubs beyond Boston and the Bay Area are giving startups new opportunities to grow and scale their businesses, ...
Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.
SK pharmteco’s ADC payload and linker solutions integrate scale, safety, and deep scientific expertise to support even the most technically demanding programs. Our right-sized, purpose-built ...
At a time of continuous change and increasing complexity, success for life sciences companies will largely depend on how they support, nurture and develop their teams. But even that has gotten more ...
Each January, the J.P. Morgan Healthcare Conference helps to set the biopharmaceutical industry agenda for the coming year, and more suits can be seen on the streets of San Francisco than during any ...
Predicting how cells behave in a bioreactor is one of the more demanding challenges in biologics manufacturing. Classical data-driven models offer a practical starting point, but they rely on fitting ...
For many families living with rare pediatric diseases, hope often arrives quietly — after years of uncertainty, missed diagnoses, and being told that treatment may never come in time. For Lindsey ...
The recipe looked perfect on paper. I'd told ChatGPT about my family's preferences for Jamaican dishes, Italian pastas, bold flavors, and it generated what seemed like ideal meal plans. The first dish ...
Regulatory submissions are entering a period of meaningful structural change. eCTD 4.0 is gaining traction at both the FDA and EMA, offering practical improvements over its predecessor: more flexible ...
Biopharma startups are conditioned to set their sights on blockbuster products, aiming out of the gate for assets that promise billions in annual sales across vast patient populations. The standard ...
Genentech’s decision to more than double its planned investment in Holly Springs marks a major expansion of North Carolina’s biomanufacturing landscape. The company is increasing its commitment from ...
A major new federal investment is accelerating efforts to address the nation’s kidney donor shortage through advanced bioprinting. With support from ARPA‑H, researchers are developing implantable, ...